News Conference News AHA 2022 Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World Michael O'Riordan November 10, 2022
News Conference News EACTS 2022 Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG Michael O'Riordan October 12, 2022
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Daily News CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES Michael O'Riordan July 22, 2022
News Daily News INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease Michael O'Riordan July 12, 2022
News Daily News LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD Michael O'Riordan July 11, 2022
News Daily News Cardiac Rehab Can Be Safely Started 2 Weeks After Surgery: SCAR Michael O'Riordan June 24, 2022
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Daily News PCI and CABG Are Complementary Options for Left Main CAD, Say Experts Michael O'Riordan April 27, 2022
News Daily News Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities Michael O'Riordan April 25, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Daily News VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery L.A. McKeown March 04, 2022
News Daily News SCAI-Defined Perioperative MIs Too Numerous to Be Useful in Cardiac Surgery Michael O'Riordan February 03, 2022
News Daily News Optimal Medical Therapy for Stable Angina: Which Drugs? How Long? Michael O'Riordan January 25, 2022
News Daily News Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines L.A. McKeown December 28, 2021
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021